Ever Supreme Bio Technology Co., Ltd (TPEX: 6712)
Taiwan
· Delayed Price · Currency is TWD 171.50
-0.50 (-0.29%)
Dec 19, 2024, 1:30 PM CST
Ever Supreme Bio Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Net Income | 254.33 | 539.4 | 200.71 | 369.6 | -106.83 | -94.22 | Upgrade
|
| Depreciation & Amortization | 30.21 | 31.8 | 34.73 | 35.14 | 31.26 | 16.07 | Upgrade
|
| Other Amortization | 0.42 | 0.51 | 0.82 | 0.68 | 0.67 | 0.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0 | -11.33 | 0.05 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | 69.87 | -241.86 | 22.7 | -261.05 | -14.31 | -9.92 | Upgrade
|
| Stock-Based Compensation | - | - | 0.79 | 2.14 | 4.22 | 8.8 | Upgrade
|
| Other Operating Activities | 56.64 | 63.59 | 32.04 | 26.66 | -30.4 | -25.36 | Upgrade
|
| Change in Accounts Receivable | -29.79 | -16.94 | -51.1 | -17.62 | -9.66 | - | Upgrade
|
| Change in Inventory | -31.13 | 19.22 | -31.53 | -21.28 | -20.73 | -14.76 | Upgrade
|
| Change in Accounts Payable | 16.65 | -5.74 | 14.08 | 9.96 | 3.88 | 1.16 | Upgrade
|
| Change in Unearned Revenue | 41.59 | 31.76 | 77.68 | 8.09 | 1.64 | 2.49 | Upgrade
|
| Change in Other Net Operating Assets | 7.79 | 0.01 | 18.27 | -5.29 | 1.74 | -6.12 | Upgrade
|
| Operating Cash Flow | 416.91 | 421.74 | 319.2 | 135.69 | -138.47 | -121.42 | Upgrade
|
| Operating Cash Flow Growth | 22.34% | 32.12% | 135.25% | - | - | - | Upgrade
|
| Capital Expenditures | -5.31 | -5.82 | -3.19 | -1.98 | -58.83 | -5.36 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 28.1 | 0.07 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.7 | -0.02 | -2.41 | -2.67 | -1.97 | -2.38 | Upgrade
|
| Investment in Securities | 217.04 | 64.31 | -279.19 | -316.21 | 216 | 168 | Upgrade
|
| Other Investing Activities | -34.95 | 3.12 | -2.52 | -4.06 | -8.5 | -19.62 | Upgrade
|
| Investing Cash Flow | 176.09 | 61.6 | -287.31 | -296.83 | 146.77 | 140.63 | Upgrade
|
| Long-Term Debt Repaid | - | -11.92 | -11.11 | -10.02 | -8.96 | -3.72 | Upgrade
|
| Net Debt Issued (Repaid) | -11.74 | -11.92 | -11.11 | -10.02 | -8.96 | -3.72 | Upgrade
|
| Issuance of Common Stock | 0.1 | 4.04 | 2.37 | 745.29 | 37.46 | - | Upgrade
|
| Repurchase of Common Stock | - | -356.35 | - | - | - | - | Upgrade
|
| Common Dividends Paid | -440.03 | -136.29 | -309.49 | - | - | - | Upgrade
|
| Other Financing Activities | -0.04 | 0.06 | -1.2 | -1.9 | 0.09 | 2.98 | Upgrade
|
| Financing Cash Flow | -451.71 | -500.47 | -319.43 | 733.36 | 28.59 | -0.74 | Upgrade
|
| Net Cash Flow | 141.28 | -17.13 | -287.53 | 572.22 | 36.89 | 18.47 | Upgrade
|
| Free Cash Flow | 411.6 | 415.92 | 316.02 | 133.7 | -197.3 | -126.78 | Upgrade
|
| Free Cash Flow Growth | 22.56% | 31.62% | 136.35% | - | - | - | Upgrade
|
| Free Cash Flow Margin | 48.72% | 54.84% | 50.36% | 30.47% | -279.48% | -1171.86% | Upgrade
|
| Free Cash Flow Per Share | 5.08 | 5.06 | 3.81 | 1.61 | -2.65 | -1.70 | Upgrade
|
| Cash Interest Paid | 0.14 | 0.2 | 0.51 | 0.62 | 0.78 | 0.58 | Upgrade
|
| Cash Income Tax Paid | 68.5 | 19.66 | 31.17 | 0.04 | -0 | -0.02 | Upgrade
|
| Levered Free Cash Flow | 288.65 | 304.48 | 219.61 | 100.32 | -148.09 | -84.78 | Upgrade
|
| Unlevered Free Cash Flow | 288.74 | 304.6 | 219.92 | 100.7 | -147.6 | -84.42 | Upgrade
|
| Change in Net Working Capital | -27.23 | -67.04 | -11.81 | 5.23 | 24.76 | 17.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.